The European Union’s drug regulator EMA says it will assess Johnson & Johnson’s Covid-19 Vaccine Janssen after “four serious cases of unusual blood clots” occurred in people who received the jab in the US. The statement from EMA’s Pharmacovigilance Risk Assessment Committee says one case occurred in a clinical trial and three others during the vaccine rollout in the US. One of the cases was fatal. Covid-19 vaccine Janssen is currently only used in the USA but the rollout in the EU is expected within the next few weeks. The EMA authorised the jab for use in the EU in March. The agency says the cases are being investigated and currently
Hence then, the article about johnson johnson s covid 19 vaccine under investigation in eu over potential link to unusual blood clots was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Johnson & Johnson’s Covid-19 vaccine under investigation in EU over potential link to ‘unusual’ blood clots )